Schematic drawing showing the principles of Eisenmenger's syndrome
|Classification and external resources|
|ICD-9-CM||745.4 (CDC/BPA 745.410)|
Eisenmenger's syndrome (or ES, Eisenmenger's reaction or tardive cyanosis) is defined as the process in which a left to right shunt caused by a congenital heart defect in the fetal heart causes increased flow through the pulmonary vasculature, causing pulmonary hypertension, which in turn causes increased pressures in the right side of the heart and reversal of the shunt into a right-to-left shunt.
Eisenmenger syndrome is a cyanotic heart defect characterized by a long-standing intracardiac shunt (caused by ventricular septal defect, atrial septal defect, or less commonly, patent ductus arteriosus) that eventually reverses to a right-to-left shunt. This syndrome is less frequent today because of medical screening with echocardiography early in life.
Eisenmenger's syndrome can cause serious complications in pregnancy, though successful delivery has been reported. Maternal mortality ranges from 30% to 60%, and may be attributed to fainting spells, thromboembolism, hypovolemia, hemoptysis or preeclampsia. Most deaths occur either during or within the first weeks after delivery. Pregnant women with Eisenmenger syndrome should be hospitalized after the 20th week of pregnancy - or earlier if clinical deterioration occurs.
Signs and symptoms
Signs and symptoms of Eisenmenger syndrome include the following:
- Cyanosis (a blue tinge to the skin resulting from lack of oxygen)
- High red blood cell count
- Swollen or clubbed finger tips (clubbing)
- Fainting (also known as syncope)
- Heart failure
- Abnormal heart rhythms
- Bleeding disorders
- Coughing up blood
- Iron deficiency
- Infections (endocarditis and pneumonia)
- Kidney problems
- Gout (rarely) due to increased uric acid resorption and production with impaired excretion
A number of congenital heart defects can cause Eisenmenger syndrome, including atrial septal defects, ventricular septal defects, patent ductus arteriosus, and more complex types of acyanotic heart disease.
The larger and more muscular left side of the heart generates the high pressure required to supply blood to the brain and body. The systemic circulation derived from the left heart is a high pressure circuit. The smaller, right side of the heart generates the lower pressure required to circulate blood to the lungs. The pulmonary circulation derived from the right heart is a low pressure circuit.
If a significant anatomic defect (i.e. a hole or breach) exists between the two sides of the heart causing a shunt, blood will flow from the left side to the right side (because the right side has less resistance) in a curve proportional to the magnitude of the breach. This results in higher than normal blood flow and pressure directed to the lungs. High blood pressure in the right heart circuit (from any cause) is generally known as pulmonary hypertension. A sustained intracardiac breach or shunt from the left to the right circulation then results in maladaptive remodeling of the left and right heart ventricles to accommodate the mismatched pressures encountered. The beat-to-beat volume of blood pumped through a left-to-right breach is a percentage of cardiac output (CO). Clinically a low index or percentage of CO ejected through a shunt is harmless; a high index or percentage of CO ejected through a left-to-right shunt heralds Eisenmenger's physiology.
Increased right-sided blood pressure causes a cascade of pathologic damage to the delicate pulmonary capillaries, causing them to be incrementally replaced with scar tissue. Scar (dead lung tissue) does not contribute to oxygen transfer, therefore decreasing the useful volume of the pulmonary vasculature. The scar tissue also provides less flexibility and compliance than normal lung tissue, causing further increases in pulmonary blood pressure, and the weakened heart must pump harder to continue supplying the lungs, leading to damage of more capillaries.
Eventually, due to increased resistance and decreased compliance of the pulmonary vessels, elevated pulmonary pressures cause the myocardium representing the right heart to hypertrophy, commonly understood as right ventricular hypertrophy (RVH). Eisenmenger's syndrome-derived RVH may cause an increase in right heart pressure that becomes sufficient to reverse blood flow through the breach, allowing blood to travel from the right side of the heart to the left side. The body is then supplied with deoxygenated blood (which bypassed the lungs by flowing directly from the right heart to the left heart), leading to cyanosis and resultant organ damage. In an infant with significant Eisenmenger physiology the skin is typically insufficiently oxygenated resulting in the antiquated medical term of "blue baby syndrome".
The reduction in oxygen transfer reduces oxygen saturation in the blood, leading to increased production of red blood cells in an attempt to increase oxygen delivery. The excess of red blood cells is often labeled polycythemia although only one blood cell line is increased. Desperate for enough circulating oxygen, the body begins to tax the bone marrow (where red blood cells are generated) and dump immature red cells into the spleen and bloodstream. Immature red cells are not as efficient at carrying oxygen as mature red cells and they are less flexible and less able to easily squeeze through tiny capillaries in the lungs. This contributes to the death of pulmonary capillary beds. The increase in red blood cells also causes the hyperviscosity syndrome.
A person with Eisenmenger's syndrome is paradoxically subject to the possibility of both uncontrolled bleeding due to damaged capillaries and high pressure, and random clots due to hyperviscosity and stasis of blood.
If the hole in the heart is identified before it causes pulmonary hypertension, it can normally be repaired through surgery preventing the disease. After pulmonary hypertension, a heart–lung transplant or a lung transplant with repair of the heart is a possible option. Transplantation is the final therapeutic option and only for patients with poor prognosis and quality of life. Timing and appropriateness of transplantation remain difficult decisions. 5-year and 10-year survival ranges between 70% and 80%, 50% and 70%, 30% and 50%, respectively. Since the average life expectancy of patients after lung transplantation is as low as 30% at 5 years, patients with reasonable functional status related to Eisenmenger syndrome have improved survival with conservative medical care compared with transplantation.
Various medicines and therapies for pulmonary hypertension are under investigation for treatment of the symptoms.
- Jensen AS, Iversen K, Vejlstrup NG, Hansen PB, Søndergaard L (April 2009). "[Eisenmenger syndrome]". Ugeskrift for Laeger (in Danish) 171 (15): 1270–5. PMID 19416617.
- "Eisenmenger syndrome" at Dorland's Medical Dictionary
- Siddiqui S, Latif N (2008). "PGE1 nebulisation during caesarean section for Eisenmenger's syndrome: a case report". J Med Case Reports 2 (1): 149. doi:10.1186/1752-1947-2-149. PMC 2405798. PMID 18466628.
- Makaryus AN, Forouzesh A, Johnson M (November 2006). "Pregnancy in the patient with Eisenmenger's syndrome". Mt. Sinai J. Med. 73 (7): 1033–6. PMID 17195894.
- Curr Cardiol Rev. 2010 November; 6(4): 363–372.The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects Erwin Oechslin, Siegrun Mebus, Ingram Schulze-Neick, Koichiro Niwa, Pedro T Trindade, Andreas Eicken, Alfred Hager, Irene Lang, John Hess, and Harald Kaemmerer [PMCID:PMC3083818]
- Wood, P (1958). "Pulmonary hypertension with special reference to the vasoconstrictive factor.". British heart journal 20 (4): 557–70. doi:10.1136/hrt.20.4.557. PMC 491807. PMID 13584643.
- Eisenmenger V. Die angeborenen Defekte der Kammerscheidewände des Herzens. The condition was first mentioned by Hippocrates, the Greek physician. Zeitschr Klin Med 1897;32(Supplement):1-28.
- synd/3034 at Who Named It?
- Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. P 1617-1618. Ann Intern Med 1998; 128:745-755
- "Eisenmenger syndrome". NIH MedLine Plus. 2010-02-05.
- Goerler H, Simon A, Gohrbandt B, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg. 2007;32(6):926–31. [PubMed]
- Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21(7):731–7. [PubMed]
- Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Stoica SC, McNeil KD, Perreas K, Sharples LD, Satchithananda DK, Tsui SS, Large SR, Wallwork J Ann Thorac Surg. 2001 Dec; 72(6):1887-91.
- "Eisenmenger Syndrome Treatment & Management". MedScape Reference. 2008-06-05.
|Wikimedia Commons has media related to Eisenmenger's syndrome.|
- Mayo Clinic, "Detailed Description of Eisenmenger's Syndrome"
- Down's Heart Group, "Easily understood description of Eisenmenger's Syndrome and how it affects people with Down's Syndrome who have unoperated congenital heart defects."